![James M. Shanahan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
James M.
Shanahan was the founder of Jam Technologies, Inc. where he held the title of Vice President-Marketing from 1999 to 2009.
Mr. Shanahan is also the founder of SynDevRx, Inc.
James M. Shanahan active positions
Companies | Position | Start |
---|---|---|
SynDevRx, Inc.
![]() SynDevRx, Inc. Miscellaneous Commercial ServicesCommercial Services SynDevRx, Inc. develops treatments for metabolic-related diseases. Its product includes SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active small molecule fumagillol derivative in vivo. The company was founded by James M. Shanahan and Bradley J. Carver and is headquartered in Cambridge, MA. | Founder | - |
Former positions of James M. Shanahan
Companies | Position | End |
---|---|---|
Jam Technologies, Inc.
![]() Jam Technologies, Inc. SemiconductorsElectronic Technology Jam Technologies, Inc. manufactures and supplies semiconductor devices. The company designs audio system interface chips for audio-centric consumer electronics, including flat panel TVs, computers, and portable media players. It offers True Fidelity sub-ranging pulse width modulation digital amplifiers. Jam Technologies was founded by James M. Shanahan & Larry Kirn in 1999 and is headquartered in Austin, TX | Founder | 20/01/2009 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Jam Technologies, Inc.
![]() Jam Technologies, Inc. SemiconductorsElectronic Technology Jam Technologies, Inc. manufactures and supplies semiconductor devices. The company designs audio system interface chips for audio-centric consumer electronics, including flat panel TVs, computers, and portable media players. It offers True Fidelity sub-ranging pulse width modulation digital amplifiers. Jam Technologies was founded by James M. Shanahan & Larry Kirn in 1999 and is headquartered in Austin, TX | Electronic Technology |
SynDevRx, Inc.
![]() SynDevRx, Inc. Miscellaneous Commercial ServicesCommercial Services SynDevRx, Inc. develops treatments for metabolic-related diseases. Its product includes SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active small molecule fumagillol derivative in vivo. The company was founded by James M. Shanahan and Bradley J. Carver and is headquartered in Cambridge, MA. | Commercial Services |
- Stock Market
- Insiders
- James M. Shanahan